Results 101 to 110 of about 42,497 (216)

Aplastic anemia associated with interferon alpha 2a in a patient with chronic hepatitis C virus infection: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction Hepatitis-associated aplastic anemia is a common syndrome in patients with bone marrow failure. However, hepatitis-associated aplastic anemia is an immune-mediated disease that does not appear to be caused by any of the known hepatitis ...
Ioannou Savvas   +3 more
doaj   +1 more source

Modern concepts of the platelet in health and disease [PDF]

open access: yes, 1962
Thesis (M.D.)--Boston ...
Estes, J. Worth
core  

Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. [PDF]

open access: yes, 2020
Since 2013, the International Union of Immunological Societies (IUIS) expert committee (EC) on Inborn Errors of Immunity (IEI) has published an updated phenotypic classification of IEI, which accompanies and complements their genotypic classification ...
Ailal, Fatima   +18 more
core  

Distinct routes of lineage development reshape the human blood hierarchy across ontogeny [PDF]

open access: yes, 2012
In a classical view of hematopoiesis, the various blood cell lineages arise via a hierarchical scheme starting with multipotent stem cells that become increasingly restricted in their differentiation potential through oligopotent and then unipotent ...
Notta, Faiyaz   +13 more
core   +1 more source

Trends in US Hematology/Oncology Physician Perceptions and Referral Practices for Hematopoietic Cell Transplant: A National Survey Conducted by NMDP

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background To evaluate trends in allogeneic hematopoietic cell transplant (HCT) referral perceptions and practices, we compared surveys of Hematology‐Oncology (Hem‐Onc) physicians conducted in 2015 (N = 150), 2019 (N = 302), and 2024 (N = 183) and reported changes over time.
Aye Mon Thida   +7 more
wiley   +1 more source

Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma

open access: yesCase Reports in Oncology, 2019
Nivolumab is an active treatment in patients with metastatic melanoma. We report a case of a patient with metastatic malignant melanoma who was given nivolumab as an advanced-line treatment.
Keren Rouvinov   +4 more
doaj   +1 more source

Health Hazard Manual for Firefighters [PDF]

open access: yes, 1990
[Excerpt] Firefighters, as well as victims, can be exposed to a variety of toxic substances during a fire. Some of these toxicants are particularly insidious because they are produced by thermal decomposition before smoke makes a fire ...
Brown, Nellie J.
core   +1 more source

Causation in Tort: General Populations vs. Individual Cases [PDF]

open access: yes, 2014
To establish causation, a tort plaintiff must show that it is “more probable than not” that the harm would not have occurred if the defendant had followed the relevant standard of care.
Meadow, William, Sunstein, Cass Robert
core  

Pharmacokinetics and Customized Dosing of Vancomycin in Adult Patients With Hematological Malignancies: Status, Challenges, and Opportunities

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
Framework diagram of CDvan informed by MCS (Eucast, European committee for antimicrobial susceptibility testing; CLSI, clinical and laboratory standard institute). ABSTRACT Vancomycin (VAN) remains the first‐line treatment for methicillin‐resistant, multidrug‐resistant gram‐positive bacterial infections, even among cancer patients.
Xiangqing Song   +3 more
wiley   +1 more source

Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment

open access: yesBlood Advances, 2018
: Treatment of severe aplastic anemia has improved significantly over the past 4 decades. This review will summarize the key areas of progress in the use of allogeneic hematopoietic cell transplantation and nontransplant immunosuppressive therapy (IST ...
George E. Georges   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy